Chronic hepatitis delta virus (HDV) infection.

Area of Science:

• Hepatology
• Virology
• Infectious Diseases

Background:

• Hepatitis Delta Virus (HDV) is a unique RNA virus dependent on Hepatitis B Virus (HBV) for replication.
• HDV infection is endemic in the Mediterranean basin and prevalent among specific risk groups globally.
• HDV superinfection in chronic HBV carriers can lead to severe hepatitis and cirrhosis, while co-infection may cause fulminant hepatitis.

Purpose of the Study:

• To review the key features of chronic Hepatitis Delta Virus infection.
• To discuss diagnostic methods and potential therapeutic strategies for HDV.
• To highlight the clinical significance and epidemiological patterns of HDV.

Main Methods:

• Review of existing literature on HDV infection.
• Discussion of diagnostic techniques including antigen detection, antibody testing, and molecular methods (PCR).
• Exploration of serological markers such as autoantibodies (anti-LKM, anti-forestomach basal cell layer).

Main Results:

• HDV infection necessitates concurrent HBV infection.
• Diagnostic methods include detecting HDV antigen, anti-HD antibodies, and HDV-RNA via PCR.
• A significant percentage of chronic HDV patients exhibit specific autoantibodies.
• Clinical outcomes range from severe chronic hepatitis to fulminant hepatitis.

Conclusions:

• Chronic HDV infection presents significant clinical challenges, often linked to severe liver disease.
• Accurate diagnosis relies on a combination of serological and molecular assays.
• Therapeutic options, including interferon and liver transplantation, require further evaluation.